Related Experiment Video
Updated: Apr 20, 2026

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
Interference of Aspergillus fumigatus with the immune response
Thorsten Heinekamp1, Hella Schmidt, Katrin Lapp
1Department of Molecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology (HKI), Jena, Germany, thorsten.heinekamp@hki-jena.de.
Abstract:
Aspergillus fumigatus is a saprotrophic filamentous fungus and also the most prevalent airborne fungal pathogen of humans. Depending on the host's immune status, the variety of diseases caused by A. fumigatus ranges from allergies in immunocompetent hosts to life-threatening invasive infections in patients with impaired immunity. In contrast to the majority of other Aspergillus species, which are in most cases nonpathogenic, A. fumigatus features an armory of virulence determinants to establish an infection. For example, A. fumigatus is able to evade the human complement system by binding or degrading complement regulators. Furthermore, the fungus interferes with lung epithelial cells, alveolar macrophages, and neutrophil granulocytes to prevent killing by these immune cells. This chapter summarizes the different strategies of A. fumigatus to manipulate the immune response. We also discuss the potential impact of recent advances in immunoproteomics to improve diagnosis and therapy of an A. fumigatus infection.
Insights
Aspergillus fumigatus, a common airborne fungus, causes diseases ranging from allergies to life-threatening infections by evading the human immune system. Understanding its immune evasion strategies is crucial for developing new diagnostic and therapeutic approaches.
Area of Science:
- Mycology
- Immunology
- Infectious Diseases
Background:
- Aspergillus fumigatus is a prevalent airborne fungal pathogen causing diverse diseases based on host immunity.
- It ranges from allergies in immunocompetent individuals to invasive infections in immunocompromised patients.
- Unlike most Aspergillus species, A. fumigatus possesses virulence factors enabling infection establishment.
Purpose of the Study:
- To summarize the immune evasion strategies employed by Aspergillus fumigatus.
- To discuss the role of virulence determinants in fungal pathogenesis.
- To explore the potential of immunoproteomics in improving diagnosis and therapy.
Main Methods:
- Review of scientific literature on Aspergillus fumigatus virulence and host immune interactions.
- Analysis of mechanisms used by the fungus to evade complement system and phagocytic cells.
- Discussion of recent advancements in immunoproteomics relevant to fungal infections.
Main Results:
- A. fumigatus employs multiple strategies to evade host immunity, including interference with complement regulators.
- The fungus actively manipulates lung epithelial cells, macrophages, and neutrophils to prevent immune clearance.
- Virulence factors are key to A. fumigatus establishing infections.
Conclusions:
- Aspergillus fumigatus utilizes sophisticated mechanisms to subvert host immune responses.
- Advances in immunoproteomics offer promising avenues for enhanced diagnosis and treatment of A. fumigatus infections.
- Further research into fungal immune evasion is critical for clinical management.
More Related Videos
09:52Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
15:01Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung
Published on: September 18, 2021
Related Concept Videos
Fungal Phylum Ascomycota
Antifungal Agents
Cell-mediated Immune Responses
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Drug toxicity: Drug–Drug Interaction